The neoplastic cells of EBV-positive DLBCL have a preserved B-cell program, and often exhibit an activated B-cell phenotype with expression of IRF4/MUM1 and CD30 [102,138]. Here, TNFRSF8 is linked to diffuse large B-cell lymphoma.